Concepedia

Neutrophil-to-lymphocyte ratio correlates with prognosis and response to chemotherapy in patients with non-M3 de novo acute myeloid leukemia

Qianying Zhang, Qianqian Yang, Yiqin Weng, Ziyang Huang, Rongrong Chen, Yiyi Zhu, Kanchun Dai, Shenghui Zhang, Songfu Jiang, Yu Kang

Translational Cancer Research · 2021 · 22 citations · 19 references

DOIFull text

Open access

Abstract

Pretreatment NLR as a marker can predict the prognosis and NLR can assess the response to chemotherapy in patients with non-M3 AML, especially in those cases with myeloblasts over 50% in BM.

References

19

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

John C. Byrd · Blood · 2002 · 1.6K citations

Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology

Margaret O’Donnell, Martin S. Tallman, Camille N. Abboud et al. · Journal of the National Comprehensive Cancer Network · 2017 · 651 citations · Full text

, , +14

Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short- and Long-Term Mortality in Breast Cancer Patients

Basem Azab, Vijaya Raj Bhatt, Jaya Phookan et al. · Annals of Surgical Oncology · 2011 · 556 citations

, , +9

Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response

Michael Amatangelo, Lynn Quek, Alan H. Shih et al. · Blood · 2017 · 346 citations · Full text

Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia

Alyssa Carey, David K. Edwards, Christopher A. Eide et al. · Cell Reports · 2017 · 257 citations · Full text